Ballard Spahr has further expanded its business and finance capabilities with the addition of a group of attorneys focused on corporate and securities, mergers and acquisitions, licensing, and strategic transactional matters for emerging growth and venture capital clients, firm Chair Mark Stewart announced today.
Our new partners—Carin M. Cutler, Nathan E. Seiler, and Steven N. Dupont—are based in Boulder, a growing hub for emerging growth companies and venture capital and private equity investments in the life sciences, technology, natural products, and other high-growth sectors. The office is the 15th U.S. location for Ballard Spahr and its seventh in the West.
"We were looking for a particular mix of skill and experience and we found it in this group," Mr. Stewart said. "The people drove the decision to expand to Boulder. The entrepreneurial nature of the Boulder area, coupled with our established presence in Denver and in the Western United States, made this a particularly advantageous opportunity."
Ms. Cutler and Messrs. Seiler and Dupont join the firm from Gross Cutler Seiler Dupont (GCSD), a Boulder-based boutique firm they formed after many years of practice at large national and international law firms and in senior in-house counsel positions.
"Enhancing our M&A and securities capabilities is a strategic priority and we have an increasing number of emerging growth and middle market clients in the life sciences and technology area," said Brian M. Pinheiro, Chair of Ballard Spahr's Business and Finance Department. "Carin, Nathan, and Steve are talented, innovative, and experienced, and their practices align very well with the needs of our clients."
Ms. Cutler and Mr. Seiler represent companies and investors in a wide variety of corporate transactions, including equity and debt financings by venture capital, private equity and strategic investors, mergers and acquisitions, recapitalizations, and general corporate matters. They advise public companies in equity offerings as well as on disclosure and reporting requirements, compliance with stock exchange rules, and corporate governance and securities matters.
They also advise emerging companies on entity formation, initial stock issuances, stock option plans, and angel and seed funding. Prior to GCSD, Mr. Seiler spent much of his private practice career at Cooley. Ms. Cutler practiced for more than a decade at Hogan Lovells, where she was a partner.
Mr. Dupont focuses on the corporate, licensing, and transactional needs of established and emerging life science, medical device, biotechnology, biopharmaceutical, technology, and natural products companies. He has extensive experience representing public and private companies in complex intellectual property licensing and strategic corporate alliances. Mr. Dupont served as Executive Vice President of Corporate Development and General Counsel at Pharmion Corp. In that role, he was responsible for all of the company’s legal and business development functions and led the company through its $2.9 billion acquisition by Celgene. Before that, he practiced for many years at Cooley, where he was a partner and led the Colorado technology transactions practice.
"We believe that Ballard will offer our clients the practice breadth and depth of a large, national firm while maintaining the agility and personalized client service that was the hallmark of our boutique firm," Mr. Seiler said.
"Their clients, like ours, range from start-ups to global leaders in life sciences, technology, and other expanding industries. We look forward to enhancing the services we provide to Boulder clients and helping to build the firm’s Western presence."
The attorneys in Ballard Spahr’s M&A/Private Equity Group provide in-depth deal coverage—from initial structuring through due diligence and documentation to closing and post-closing integration. The Group has more than 70 attorneys nationwide and represents buyers and sellers in transactions that span the lower-middle and middle markets and extend to multibillion-dollar transactions.